WHO ICTRP trial
Open-label, Randomized, Two-way Crossover, Two-sequence, Two-period…
TCTR20201217001 · Thai Clinical Trials Registry (TCTR) · Not Recruiting
Key facts
| Trial ID | TCTR20201217001 |
|---|---|
| Public title | Open-label, Randomized, Two-way Crossover, Two-sequence, Two-period, Two-treatment Bioequivalence Study of Dapagliflozin Tablet 10 mg in Healthy Thai Volunteers |
| Scientific title | Open-label, Randomized, Two-way Crossover, Two-sequence, Two-period, Two-treatment Bioequivalence Study of Dapagliflozin Tablet 10 mg in Healthy Thai Volunteers |
| Primary sponsor | International Bio Service Co.,Ltd. |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Thailand |
| Conditions | Bioequivalence Study, Healthy, Thai , Volunteers Dapagliflozin,Bioequivalence Study, Healthy, Thai , Volunteers;Dapagliflozin,Bioequivalence Study, Healthy, Thai , Volunteers |
| Interventions | Generic dapagliflozin 10 mg film-coated tablet, Dapagliflozin Tablets 10 mg,ForxigaTM (dapagliflozin) tablets 10 mg, Reg. No. 1C 64/57 (N), manufactured by AstraZeneca Pharmaceuticals LP, Mount Vernon, Indiana, USA and imported by… |
| Registration date | Dec 17, 2020 |
| Target size | 40 |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: